# DIEBOLD NIXDORF, Inc: Form 10-K for the period ended Dec 31, 2025

- Company: [DIEBOLD NIXDORF, Inc](/companies/dbd.md) (CIK 28823)
- Form: 10-K
- Filed: 2026-02-12
- Accepted by EDGAR: Feb 12, 2026, 16:38 ET
- Period: 2025-12-31
- Accession: 0000028823-26-000008
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/28823/000002882326000008/dbd-20251231.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/28823/000002882326000008/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2025-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2025-01-01 to 2025-12-31 | $3.81bn | us-gaap:Revenues |
| Cost of revenue | 12 months, 2025-01-01 to 2025-12-31 | $2.84bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months, 2025-01-01 to 2025-12-31 | $961.2m | us-gaap:GrossProfit |
| Research and development | 12 months, 2025-01-01 to 2025-12-31 | $86.7m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months, 2025-01-01 to 2025-12-31 | $632.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months, 2025-01-01 to 2025-12-31 | $242.0m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2025-01-01 to 2025-12-31 | $85.7m | us-gaap:InterestExpenseNonoperating |
| Income tax | 12 months, 2025-01-01 to 2025-12-31 | $24.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2025-01-01 to 2025-12-31 | $94.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2025-01-01 to 2025-12-31 | $2.54 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2025-01-01 to 2025-12-31 | $2.57 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2025-01-01 to 2025-12-31 | 37,200,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2025-01-01 to 2025-12-31 | $300.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Share repurchases | 12 months, 2025-01-01 to 2025-12-31 | $130.7m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2025-12-31 | $368.9m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2025-12-31 | $1.79bn | us-gaap:AssetsCurrent |
| Total assets | at 2025-12-31 | $3.85bn | us-gaap:Assets |
| Current liabilities | at 2025-12-31 | $1.37bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2025-12-31 | $2.75bn | us-gaap:Liabilities |
| Long-term debt | at 2025-12-31 | $938.5m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | at 2025-12-31 | $1.10bn | us-gaap:StockholdersEquity |

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/28823/000002882326000008/dbd-20251231.htm

Filed Feb 12, 2026.
Source: SEC EDGAR, the filing index for accession 0000028823-26-000008. Last ingested by Listed: Oct 28, 2026, 07:18 ET. No prices; not investment advice.